Revenue from the USA medical coding market was about US$ 937.4 Million in 2022, with the USA market estimated to surge ahead at a CAGR of 8.4% to reach a valuation of around US$ 2.3 Billion by the end of 2033.
| Attributes | Details |
|---|---|
| USA Medical Coding Market Size (2023) | US$ 1.0 Billion |
| Projected Market Value (2033) | US$ 2.3 Billion |
| Market Growth Rate (2023 to 2033) | 8.4% CAGR |
| Market Share of Top 3 Regions | 69.4% |
According to Future Market Insights, the emergency medicine segment of the USA medical coding market based on clinical specialties secured a market value of US$ 202.1 Million in 2022.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market for medical coding market in USA recorded a historic CAGR of 6.9% in the last 7 years from 2015 to 2022.
The market value of the USA medical coding was around 12.9% of the overall ~US$ 7.3 Billion of the USA revenue cycle management market in 2022.
Due to the rising prevalence of diseases, there is an increase in patient visits and admissions in healthcare settings. This will lead to increasing demand for rising adoption of digital technologies so that smooth administrative workflow can be achieved within healthcare settings.
Electronic medical records can be very efficiently used in order to check for symptoms, diseases, illnesses, and even causes of death. Apart from this, it helps healthcare professionals to check for previous medical, surgical, and diagnostic procedures that the patient has gone through. In order to facilitate the smooth documenting of medical records and enable accurate medical billing, medical coding software, and services assist in the translation of healthcare diagnosis, procedures, medical services, and equipment into universal medical alphanumeric codes. The increasing prevalence of diseases will eventually increase the number of patient visits and admissions in healthcare settings, which will require more administrative functionality. Hence, this can be considered an effective driver for the growth of the medical coding market.
The administrative practices of a hospital or any other healthcare setting are the focus of medical coding. Incorrectly manually inputted codes may result in claim denials, which can cost additional money to resolve. The hospital loses out on important revenue if the claim denials are not resolved and it is difficult to get the patient to pay what is owed. To avoid fines and other legal implications, State and Federal regulations must also be followed effortlessly in the USA
This points to the increasing need for medical coding and billing software to help in reducing the chances of these errors. Numerous errors in denied claims may actually be avoided, and by doing so, one can greatly increase collection rates. This points to the increasing use of medical coding software and services hence would impact the USA market in a positive manner.
The USA market is thus likely to show significant growth over the coming years with a CAGR of 8.4%, and reach a market size of around US$ 2.3 Billion by 2033.
Introduction and Revisions of Codes
Medical codes are used by healthcare providers and insurance companies for billing and record-keeping purposes. There are three types of medical codes being referred in the USA, the International Classification of Diseases (ICD) Codes, Current Procedural Terminology (CPT) Codes and Healthcare Common Procedure Coding (HCPCS).
For faster coding operations, medical coding software combines knowledge from all the top coding and reference books in one location. Hence, its use and demand are increasing. The introduction and revision of codes can be considered one of the driving factors for the medical coding market in USA
Apart from this, the rising demand for certified medical billers and coders creates lucrative opportunities for this market. Doctors' reports are translated into useful, standardized medical codes by medical coders. These professionals operate behind the scenes in a variety of settings, ensuring that all pertinent data is correctly coded to ensure accuracy and consistency. The insurance company or government provider has to know what was done after a medical professional evaluates or treats a patient in order to process the bill. Because the common language used to describe medical treatments is too imprecise to provide the insurance company with the precise information it requires, a set of precise codes has been created. It is the responsibility of the medical coder to convey this knowledge in a clear and effective manner.
Medical coders are required to possess a certification from the American Health Information Management Association in order to be called certified medical coders. As the horizons of digital health are widening in the USA, the demand for such professionals in the field of healthcare will increase, impacting the USA market for medical coding in a positive manner.
Other than this, the usage of AI in medical coding is considered to be the future because this brings ease to the functioning of medical coders. This presents lucrative opportunities for developers and providers of software and services in the field of medical coding.
Principal Consultant
Confidentiality and Security Concerns
Medical coders are given access to patient data that is highly confidential, and therefore, concerns regarding data security are quite high in the USA The companies have to comply with HIPAA in order to prove their compliance. This will pose a challenge to the growth of this market.
Other than this, the dearth of trained and certified medical coders is another factor that can restrain the growth of the USA market. Although there are various job positions for medical coders in the USA, the country has faced and is facing a shortage of medical coders for hospitals, physician practices, and other healthcare facilities. It is mostly the northeastern and western parts of the country that have experienced a shortage of trained medical coders. This shortage is due to the lack of awareness regarding the medical record coding professions among various graduates in the USA
Apart from this, the individuals who are currently in the profession are not able to keep up with the continuous updates and changes in the field of medical coding, leading to fewer individuals opting for this profession. This can hamper the growth of the medical coding market in the USA
The emergency medicine segment held around 21.6% share of the total USA market in 2022.
Emergency medicine is a branch of medicine that specializes in providing immediate care for illnesses and injuries. Their area of expertise is the management of unplanned, undifferentiated patients of all ages.
This points to the increasing number of billing generation in emergency medicine and hence increasing the use of medical coding software and solutions in this clinical specialty. This makes emergent medicine the dominant segment among the various clinical specialties of the USA market.
The outsourced segment held around 72.6% share of the USA market in 2022. This segment is expected to surge at a CAGR of 8.6% over the period of 2023 to 2033.
Healthcare providers are increasingly outsourcing their needs for medical coding in order to reduce administrative costs. Time is saved, costs are reduced, and workflow is streamlined by outsourcing. Hence, healthcare practitioners may prioritize the standard of patient care and patient involvement.
Market expansion is being positively impacted by the increase in onshoring and offshoring of revenue cycle management, particularly medical coding. Any hospital or healthcare facility would benefit from the well-known fact that hiring outsourced medical coding workers can reduce administrative expenditures by 25% to 30%. This makes outsourced service the dominant segment of the USA market.
Enterprise therapy practices held a significant share of about 59.0% with a market value of around US$ 294.6 Million in 2022. The enterprise therapy practices include hospitals, ambulatory surgical centers, cancer research institutes and long-term care centers. The use of medical coding solutions and software is quite high in facilities like these and therefore enterprise therapy practices held a significant share of the end user segment of the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The focus of leading companies is on expansion and growth in the various regions of this market. Many companies are concentrating on coming up with new software and solutions in the medical coding field and along with this, the companies focus on expansion through acquisitions and partnerships.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the USA medical coding space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | USD Million for Value |
| Key Countries Regions | Northeast USA, Midwest USA, Southeast USA, Southwest USA, West USA |
| Key Market Segments Covered | Clinical Specialties, Service, End User and Region |
| Key Companies Profiled | Tebra (Kareo, Inc.); Global Payments, Inc. (AdvancedMD, Inc.); EverCommerce Inc. (DrChrono Inc.); The 3M Company (3M Health Information Systems, Inc.); Greenway Health, LLC; Dolbey; GeBBS Healthcare Solutions (Aviacode Inc.); AQuity; Baruch Business Solutions; Infinx; athenahealth, Inc.; BUDDI.AI; Context4 Healthcare, Inc.; Eclat Health Solutions Inc.; Maverick Medical AI Ltd.; UnitedHealth Group Inc. (Optum, Inc.); NYM; Practolytics; Outsource Strategies International; Datavant (Ciox); PCS (Precyse Coding Solutions, LLC); Novigo Health Care Services; I-conic Solutions |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The growth potential of the USA medical coding market is 2.3% through 2033.
The adoption of alternative methods is likely to limit market growth.
The United States is likely to capture a CAGR of 8.4% through 2033.
The current market valuation is US$ 1 billion in 2023.
The market is likely to secure a valuation of US$ 2.3 billion by 2033.
1. Executive Summary | USA Medical Coding Market
1.1. USA Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Service Innovation / Development Trends
4. Value Added Insights
4.1. USA Healthcare Regulatory Timeline
4.2. The USA Healthcare Ecosystem
4.3. Medical Coding Outsourcing Services Spectrum
4.4. Medical and Risk Adjusted Coding Value Chain
4.5. Evolution of Healthcare Outsourcing Model
4.6. PESTEL Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Healthcare IT Spending Outlook, By USA & Global
5.1.2. USA per-Capita Healthcare Expenditure
5.2. Forecast Factors - Relevance & Impact
5.2.1. Government Initiatives to Encourage Healthcare IT usage
5.2.2. Introduction to Technologically Advanced Healthcare Services
5.2.3. Significant Shift towards Computer-Assisted Coding Platforms
5.2.4. Increased Demand for Centralizing and Streamlining Healthcare Workflow
5.2.5. Increasing Spending on Research and Development
5.2.6. Top Players Historical Growth
5.2.7. Reduction in Errors
5.2.8. Rise in Adoption of Medical Coding Services
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 Impact Analysis
6.1.1. By Clinical Specialties
6.1.2. By Service
6.1.3. By End User
6.1.4. By Region
6.2. COVID-19 Impact on Market
7. USA Market - Pricing Analysis
7.1. Market Pricing Analysis (Generic Pricing), By Clinical Specialties, 2022
7.2. Market Pricing Analysis (FTE (Full Time Equivalent) Pricing), By Clinical Specialties, 2022
8. USA Market Demand (in Value US$ Million) Analysis 2015 to 2022 and Forecast, 2023 to 2033
8.1. Historical Market Value (US$ Million) Analysis, 2015 to 2022
8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By Clinical Specialties
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Clinical Specialties, 2015 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Clinical Specialties, 2023 to 2033
9.3.1. Emergency Medicine
9.3.2. Diagnostic Pathology Services
9.3.3. Diagnostic Imaging
9.3.3.1. Radiology Imaging
9.3.3.2. Interventional Radiology
9.3.3.3. Nuclear Medicine
9.3.4. Inpatient Treatment
9.3.4.1. Anaesthesia and Critical Care
9.3.4.2. Cardiology & Cardiac Surgery
9.3.4.3. Gastroenterology & Hepatology
9.3.4.4. Obstetrics and Gynecology
9.3.4.5. Nephrology
9.3.4.6. Urology
9.3.4.7. Neurology & Neurosurgery
9.3.4.8. General Surgery
9.3.4.9. Orthopedics
9.3.4.10. Spinal and Pulmonology
9.3.4.11. Reproductive Medicine
9.3.4.12. Rheumatology
9.3.4.13. Dental Sciences & Cranio-Maxillo Facial Surgery
9.3.4.14. Oncology
9.3.4.15. Diabetology & Endocrinology
9.3.4.16. Pediatrics & Neonatology
9.3.4.17. Psychiatry & Clinical Psychology
9.3.4.18. Organ Transplant
9.3.5. Hospital Outpatient Treatment & Diagnostics
9.3.6. Ophthalmology
9.3.7. Dermatology
9.3.8. ENT
9.3.9. Clinical Nutrition
9.3.10. Ambulatory Surgery
9.3.11. Physician Office Visits
9.3.12. Ancillary Services
9.3.13. Observation Services
9.3.14. Others
9.4. Market Attractiveness Analysis By Clinical Specialties
10. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Service
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis by Service, 2015 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Service, 2023 to 2033
10.3.1. In-house
10.3.2. Outsourced
10.4. Market Attractiveness Analysis by Service
11. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, By End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
11.3.1. Enterprise Therapy Practices
11.3.1.1. Hospitals
11.3.1.2. Ambulatory Surgical Centers
11.3.1.3. Cancer Research Institutes
11.3.1.4. Long Term Care Centers
11.3.2. Small Therapy Practices
11.3.2.1. Specialty Clinics
11.3.2.2. Independent Physician Practices
11.3.3. Diagnostic & Reference Laboratories
11.3.4. Diagnostic Imaging Centers
11.3.5. Educational & Research Institutes
11.3.6. Healthcare Payers
11.3.7. EMS Services
11.3.8. Health Services
11.4. Market Attractiveness Analysis By End User
12. USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis by Region, 2015 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Region, 2023 to 2033
12.3.1. Northeast USA
12.3.2. Midwest USA
12.3.3. Southeast USA
12.3.4. Southwest USA
12.3.5. West USA
12.4. Market Attractiveness Analysis by Region
13. Northeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
13.3.1. By States
13.3.1.1. New York
13.3.1.2. New Jersey
13.3.1.3. Massachusetts
13.3.1.4. Rest of Northeast USA
13.3.2. By Clinical Specialties
13.3.3. By Service
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By States
13.4.2. By Clinical Specialties
13.4.3. By Service
13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
14. Midwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
14.3.1. By States
14.3.1.1. Wisconsin
14.3.1.2. Minnesota
14.3.1.3. Rest of Midwest USA
14.3.2. By Clinical Specialties
14.3.3. By Service
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By States
14.4.2. By Clinical Specialties
14.4.3. By Service
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
15. Southeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
15.3.1. By States
15.3.1.1. North Carolina
15.3.1.2. South Carolina
15.3.1.3. Florida
15.3.1.4. Virginia
15.3.1.5. Rest of Southeast USA
15.3.2. By Clinical Specialties
15.3.3. By Service
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By States
15.4.2. By Clinical Specialties
15.4.3. By Service
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
16. Southwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 - 2032
16.3.1. By States
16.3.1.1. Louisiana
16.3.1.2. Oklahoma
16.3.1.3. Texas
16.3.1.4. Rest of Southeast USA
16.3.2. By Clinical Specialties
16.3.3. By Service
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By States
16.4.2. By Clinical Specialties
16.4.3. By Service
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
17. West USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2015 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2022 to 2032
17.3.1. By States
17.3.1.1. Washington
17.3.1.2. California
17.3.1.3. New Mexico
17.3.1.4. Rest of West USA
17.3.2. By Clinical Specialties
17.3.3. By Service
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By States
17.4.2. By Clinical Specialties
17.4.3. By Service
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
Software Vendors:
18.3.1. Tebra (Kareo, Inc.)
18.3.1.1. Overview
18.3.1.2. Solution Portfolio
18.3.1.3. Key Financial
18.3.1.4. Sales Footprint
18.3.1.5. SWOT Analysis
18.3.1.6. Strategy Overview
18.3.1.6.1. Marketing Strategy
18.3.1.6.2. Product Strategy
18.3.1.6.3. Channel Strategy
18.3.2. Global Payments, Inc. (AdvancedMD, Inc.)
18.3.2.1. Overview
18.3.2.2. Solution Portfolio
18.3.2.3. Key Financial
18.3.2.4. Sales Footprint
18.3.2.5. SWOT Analysis
18.3.2.6. Strategy Overview
18.3.2.6.1. Marketing Strategy
18.3.2.6.2. Product Strategy
18.3.2.6.3. Channel Strategy
18.3.3. EverCommerce Inc. (DrChrono Inc.)
18.3.3.1. Overview
18.3.3.2. Solution Portfolio
18.3.3.3. Key Financial
18.3.3.4. Sales Footprint
18.3.3.5. SWOT Analysis
18.3.3.6. Strategy Overview
18.3.3.6.1. Marketing Strategy
18.3.3.6.2. Product Strategy
18.3.3.6.3. Channel Strategy
18.3.4. The 3M Company (3M Health Information Systems, Inc.)
18.3.4.1. Overview
18.3.4.2. Solution Portfolio
18.3.4.3. Key Financial
18.3.4.4. Sales Footprint
18.3.4.5. SWOT Analysis
18.3.4.6. Strategy Overview
18.3.4.6.1. Marketing Strategy
18.3.4.6.2. Product Strategy
18.3.4.6.3. Channel Strategy
18.3.5. Greenway Health, LLC
18.3.5.1. Overview
18.3.5.2. Solution Portfolio
18.3.5.3. Key Financial
18.3.5.4. Sales Footprint
18.3.5.5. SWOT Analysis
18.3.5.6. Strategy Overview
18.3.5.6.1. Marketing Strategy
18.3.5.6.2. Product Strategy
18.3.5.6.3. Channel Strategy
18.3.6. Dolbey
18.3.6.1. Overview
18.3.6.2. Solution Portfolio
18.3.6.3. Key Financial
18.3.6.4. Sales Footprint
18.3.6.5. SWOT Analysis
18.3.6.6. Strategy Overview
18.3.6.6.1. Marketing Strategy
18.3.6.6.2. Product Strategy
18.3.6.6.3. Channel Strategy
18.3.7. GeBBS Healthcare Solutions (Aviacode Inc.)
18.3.7.1. Overview
18.3.7.2. Solution Portfolio
18.3.7.3. Key Financial
18.3.7.4. Sales Footprint
18.3.7.5. SWOT Analysis
18.3.7.6. Strategy Overview
18.3.7.6.1. Marketing Strategy
18.3.7.6.2. Product Strategy
18.3.7.6.3. Channel Strategy
18.3.8. AQuity
18.3.8.1. Overview
18.3.8.2. Solution Portfolio
18.3.8.3. Key Financial
18.3.8.4. Sales Footprint
18.3.8.5. SWOT Analysis
18.3.8.6. Strategy Overview
18.3.8.6.1. Marketing Strategy
18.3.8.6.2. Product Strategy
18.3.8.6.3. Channel Strategy
18.3.9. Baruch Business Solutions
18.3.9.1. Overview
18.3.9.2. Solution Portfolio
18.3.9.3. Key Financial
18.3.9.4. Sales Footprint
18.3.9.5. SWOT Analysis
18.3.9.6. Strategy Overview
18.3.9.6.1. Marketing Strategy
18.3.9.6.2. Product Strategy
18.3.9.6.3. Channel Strategy
18.3.10. Infinx
18.3.10.1. Overview
18.3.10.2. Solution Portfolio
18.3.10.3. Key Financial
18.3.10.4. Sales Footprint
18.3.10.5. SWOT Analysis
18.3.10.6. Strategy Overview
18.3.10.6.1. Marketing Strategy
18.3.10.6.2. Product Strategy
18.3.10.6.3. Channel Strategy
18.3.11. athenahealth, Inc.
18.3.11.1. Overview
18.3.11.2. Solution Portfolio
18.3.11.3. Key Financial
18.3.11.4. Sales Footprint
18.3.11.5. SWOT Analysis
18.3.11.6. Strategy Overview
18.3.11.6.1. Marketing Strategy
18.3.11.6.2. Product Strategy
18.3.11.6.3. Channel Strategy
18.3.12. BUDDI.AI
18.3.12.1. Overview
18.3.12.2. Solution Portfolio
18.3.12.3. Key Financial
18.3.12.4. Sales Footprint
18.3.12.5. SWOT Analysis
18.3.12.6. Strategy Overview
18.3.12.6.1. Marketing Strategy
18.3.12.6.2. Product Strategy
18.3.12.6.3. Channel Strategy
18.3.13. Context4 Healthcare, Inc.
18.3.13.1. Overview
18.3.13.2. Solution Portfolio
18.3.13.3. Key Financial
18.3.13.4. Sales Footprint
18.3.13.5. SWOT Analysis
18.3.13.6. Strategy Overview
18.3.13.6.1. Marketing Strategy
18.3.13.6.2. Product Strategy
18.3.13.6.3. Channel Strategy
18.3.14. Eclat Health Solutions Inc.
18.3.14.1. Overview
18.3.14.2. Solution Portfolio
18.3.14.3. Key Financial
18.3.14.4. Sales Footprint
18.3.14.5. SWOT Analysis
18.3.14.6. Strategy Overview
18.3.14.6.1. Marketing Strategy
18.3.14.6.2. Product Strategy
18.3.14.6.3. Channel Strategy
18.3.15. Maverick Medical AI Ltd.
18.3.15.1. Overview
18.3.15.2. Solution Portfolio
18.3.15.3. Key Financial
18.3.15.4. Sales Footprint
18.3.15.5. SWOT Analysis
18.3.15.6. Strategy Overview
18.3.15.6.1. Marketing Strategy
18.3.15.6.2. Product Strategy
18.3.15.6.3. Channel Strategy
18.3.16. UnitedHealth Group Inc. (Optum, Inc.)
18.3.16.1. Overview
18.3.16.2. Solution Portfolio
18.3.16.3. Key Financial
18.3.16.4. Sales Footprint
18.3.16.5. SWOT Analysis
18.3.16.6. Strategy Overview
18.3.16.6.1. Marketing Strategy
18.3.16.6.2. Product Strategy
18.3.16.6.3. Channel Strategy
18.3.17. NYM
18.3.17.1. Overview
18.3.17.2. Solution Portfolio
18.3.17.3. Key Financial
18.3.17.4. Sales Footprint
18.3.17.5. SWOT Analysis
18.3.17.6. Strategy Overview
18.3.17.6.1. Marketing Strategy
18.3.17.6.2. Product Strategy
18.3.17.6.3. Channel Strategy
Services Providers:
18.3.18. Practolytics
18.3.18.1. Overview
18.3.18.2. Solution Portfolio
18.3.18.3. Key Financial
18.3.18.4. Sales Footprint
18.3.18.5. SWOT Analysis
18.3.18.6. Strategy Overview
18.3.18.6.1. Marketing Strategy
18.3.18.6.2. Product Strategy
18.3.18.6.3. Channel Strategy
18.3.19. Outsource Strategies International
18.3.19.1. Overview
18.3.19.2. Solution Portfolio
18.3.19.3. Key Financial
18.3.19.4. Sales Footprint
18.3.19.5. SWOT Analysis
18.3.19.6. Strategy Overview
18.3.19.6.1. Marketing Strategy
18.3.19.6.2. Product Strategy
18.3.19.6.3. Channel Strategy
18.3.20. Datavant (Ciox)
18.3.20.1. Overview
18.3.20.2. Solution Portfolio
18.3.20.3. Key Financial
18.3.20.4. Sales Footprint
18.3.20.5. SWOT Analysis
18.3.20.6. Strategy Overview
18.3.20.6.1. Marketing Strategy
18.3.20.6.2. Product Strategy
18.3.20.6.3. Channel Strategy
18.3.21. PCS (Precyse Coding Solutions, LLC)
18.3.21.1. Overview
18.3.21.2. Solution Portfolio
18.3.21.3. Key Financial
18.3.21.4. Sales Footprint
18.3.21.5. SWOT Analysis
18.3.21.6. Strategy Overview
18.3.21.6.1. Marketing Strategy
18.3.21.6.2. Product Strategy
18.3.21.6.3. Channel Strategy
18.3.22. Novigo Health Care Services
18.3.22.1. Overview
18.3.22.2. Solution Portfolio
18.3.22.3. Key Financial
18.3.22.4. Sales Footprint
18.3.22.5. SWOT Analysis
18.3.22.6. Strategy Overview
18.3.22.6.1. Marketing Strategy
18.3.22.6.2. Product Strategy
18.3.22.6.3. Channel Strategy
18.3.23. I-conic Solutions
18.3.23.1. Overview
18.3.23.2. Solution Portfolio
18.3.23.3. Key Financial
18.3.23.4. Sales Footprint
18.3.23.5. SWOT Analysis
18.3.23.6. Strategy Overview
18.3.23.6.1. Marketing Strategy
18.3.23.6.2. Product Strategy
18.3.23.6.3. Channel Strategy
19. Assumptions and Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
USA Medical Coding Market
